WASHINGTON (Reuters) - Novartis AG has won U.S. antitrust approval to buy GlaxoSmithKline’s oncology drugs, with conditions, the U.S. Federal Trade Commission said on Monday.
Canada's competition agency also said on Monday that it would allow the deal to go forward.
02:11 Murdoch Pounces on Sky as Lower Pound Makes Takeover Cheaper6
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth13
08:17 Trump chooses former WWE exec McMahon for small business18
21:17 Lawmakers Change Their Tone on AT&T and Time Warner Deal23